Chemistry: natural resins or derivatives; peptides or proteins; – Proteins – i.e. – more than 100 amino acid residues – Lymphokines – e.g. – interferons – interlukins – etc.
Reexamination Certificate
2007-12-04
2007-12-04
O'Hara, Eileen (Department: 1647)
Chemistry: natural resins or derivatives; peptides or proteins;
Proteins, i.e., more than 100 amino acid residues
Lymphokines, e.g., interferons, interlukins, etc.
C435S069100, C435S071100, C435S320100, C435S471000, C536S023500
Reexamination Certificate
active
11107572
ABSTRACT:
The present invention provides novel polynucleotides encoding HLRRBM1 polypeptides, fragments and homologues thereof. Also provided are vectors, host cells, antibodies, and recombinant and synthetic methods for producing said polypeptides. The invention further relates to diagnostic and therapeutic methods for applying these novel HLRRBM1 polypeptides to the diagnosis, treatment, and/or prevention of various diseases and/or disorders related to these polypeptides, particularly immune diseases and/or disorders. The invention further relates to screening methods for identifying agonists and antagonists of the polynucleotides and polypeptides of the present invention.
REFERENCES:
patent: 5849902 (1998-12-01), Arrow et al.
patent: WO 01/75067 (2001-10-01), None
patent: WO 02/40668 (2002-05-01), None
patent: WO 02/061049 (2002-08-01), None
Elbendary et al, Clinical Cancer research, 1996, vol. 2, pp. 1571-1575.
Inohara et al. (1999) J. of Biological Chemistry 274:14560-14567.
NCBI Entrez Accession No. AAA40132 (gi:201045), Dickinson, D.P. et al., Apr. 27, 1993.
NCBI Entrez Accession No. AAC39910 (gi:3341996), Mao, M. et al., May 22, 2001.
NCBI Entrez Accession No. AAG15254 (gi:10198209), Bertin, J. et al., Feb. 19, 2002.
NCBI Entrez Accession No. AAH28069 (gi:20380400), Strausberg, R.L. et al., Jun. 29, 2004.
NCBI Entrez Accession No. AAL12497 (gi:17027237), Hoffman, H.M. et al., Nov. 21, 2001.
NCBI Entrez Accession No. AAM18227 (gi:21314907), Wang, L. et al., Aug. 12, 2002.
NCBI Entrez Accession No. AAM75142 (gi:21711821), Williams, K.L. et al., May 21, 2003.
NCBI Entrez Accession No. AAM75143 (gi:21711823), Williams, K.L. et al., May 21, 2003.
NCBI Entrez Accession No. AAM75144 (gi:21711825), Wiiliams, K.L. et al., May 21, 2003.
NCBI Entrez Accession No. AAM75145 (gi:21711827), Williams, K.L. et al., May 21, 2003.
NCBI Entrez Accession No. AAO18163 (gi:28436378), Tschopp, J. et al., Feb. 20, 2003.
NCBI Entrez Accession No. AF231021 (gi:13182796), Shami, P.J. et al., Apr. 30, 2004.
NCBI Entrez Accession No. AY095146 (gi:21314906), Wang, L. et al., Aug. 12, 2002.
NCBI Entrez Accession No. BC028069 (gi:20380399), Strausberg, R.L. et al., Jun. 29, 2004.
NCBI Entrez Accession No. CAD35284 (gi:21449785), Reed, J.C. et al., Jun. 14, 2002.
NCBI Entrez Accession No. NP—006083 (gi:5174617), Kim, J.G. et al., Oct. 28, 2004.
NCBI Entrez Accession No. NP—055737 (gi:7662386), Tschopp, J. et al., Oct. 28, 2004.
NCBI Entrez Accession No. NP—653288 (gi:21955154), Williams, K.L. et al., Oct. 27, 2004.
NCBI Entrez Accession No. P59046 (gi:24212103), Wang, L. et al., Sep. 15, 2003.
Altschul, S.F. et al., “Gapped BLAST and PSI-BLAST: a new generation of protein database search programs”, Nucleic Acids Research, vol. 25, No. 17, pp. 3389-3402 (1997).
Bause, E., “Structural requirements ofN-glycosylation of proteins: Studies with proline peptides as conformational probes”, Biochem. J., vol. 209, pp. 331-336 (1983).
Bengtsson, E. et al., “The Primary Structure of a Basic Leucine-rich Repeat Protein, PRELP, Found in Connective Tissues”, The Journal of Biological Chemistry, vol. 270, No. 43, pp. 25639-25644 (1995).
Bertin, J. et al., “Human CARD4 Protein is a Novel CED-4/Apaf-1 Cell Death Family Member That Activates NF-κB”, The Journal of Biological Chemistry, vol. 274, No. 19, pp. 12955-12958 (1999).
Bertin, J. et al., “The PYRIN domain: a novel motif found in apoptosis and inflammation proteins”, Cell Death and Differentiation, vol. 7, pp. 1273-1274 (2000).
Buchanan, S.G.S.C. et al., “Structural and Functional Diversity in the Leucine-Rich Repeat Family of Proteins”, Prog. Biophys. Molec. Biol., vol. 65, No. 1/2, pp. 1-44 (1996).
Bunz, F. et al., “Requirement for p53 and p21 to Sustain g2Arrest After DNA Damage”, Science, vol. 282, pp. 1497-1501 (1998).
Cheng, T. et al., “Hematopoietic Stem Cell Quiescence Maintained by p21cip/waf1”, Science, vol. 287, pp. 1804-1808 (2000).
Collins, N. et al., “Molecular Characterization of the MaizeRp1-DRust Resistance Haplotype and Its Mutants”, The Plant Cell, vol. 11, pp. 1365-1376 (1999).
Dixon, J. et al., “Increased levels of apoptosis in the prefusion neural folds underlie the craniofacial disorder, Treacher Collins syndrome”, Human Molecular Genetics, vol. 9, No. 10, pp. 1473-1480 (2000).
Dixon, M.S. et al., “Genetic complexity of pathogen perception by plants: The example ofRcr3, a tomato gene required specifically byCf-2”, Proc. Natl. Acad. Sci., vol. 97, No. 16, pp. 8807-8814 (2000).
Dixon, M.S. et al., “The TomatoCf-5Disease Resistance Gene and Six Homologs Show Pronounced Allelic Variation in Leucine-Rich Repeat Copy Number”, The Plant Cell, vol. 10, pp. 1915-1925 (1998).
Draetta, G.F., “Mammalian G1cyclins”, Current Opinion in Cell Biology, vol. 6, pp. 842-846 (1994).
Eldon, E. et al., “TheDrosophila 18 wheeleris required for morphogenesis and has striking similarities toToll”, Development, vol. 120, pp. 885-899 (1994).
Ellis, J. et al., “Structure and function of proteins controlling strain-specific pathogen resistance in plants”, Current Opinion in Plant Biology, vol. 1, pp. 288-293 (1998).
Gavel, Y. et al., “Sequence differences between glycosylated and non-glycosylated Asn-X-Thr/Ser acceptor sites: implications for protein engineering”, Protein Engineering, vol. 3, No. 5, pp. 433-442 (1990).
Gavrieli, Y. et al., “Identification of Programmed Cell Death in Situ via Specific Labeling of Nuclear DNA Fragmentation”, The Journal of Cell Biology, vol. 119, No. 3, pp. 493-501 (1992).
Graham, M.A. et al., “Expression and genome organization of resistance gene analogs in soybean”, Genome, vol. 43, pp. 86-93 (2000).
Halfon, M.S. et al., “TheDrosophila TollGene Functions Zygotically and is Necessary for Proper Motoneuron and Muscle Development”, Developmental Biology, vol. 169, pp. 151-167 (1995).
Harton, J.A. et al., “Class II Transactivator: Mastering the Art of Major Histocompatibility Complex Expression”, Molecular and Cellular Biology, vol. 20, No. 17, pp. 6185-6194 (2000).
Hayashi, T. et al., “Molecular Pathogenesis of Bernard-Soulier Syndrome”, Seminars in Thrombosis and Hemostasis, vol. 26, No. 1, pp. 53-59 (2000).
He, Z. et al., “Perception of Brassinosteroids by the Extracellular Domain of the Receptor Kinase BRI1”, Science, vol. 288, pp. 2360-2363 (2000).
Hofmann, K. et al., MF C-35: “A Database of Membrane Spanning Protein Segments”, Biol. Chem. Hoppe-Seyler, vol. 374, p. 166 (1993).
Imai, Y. et al., “The CED-4-homologous protein FLASH is involved in Fas-mediated activation of caspase-8 during apoptosis”, Nature, vol. 398, pp. 777-785 (1999).
Inohara, N. et al., “An Induced Proximity Model for NF-κB Activation in the Nod1/RICK and RIP Signaling Pathways”, The Journal of Biological Chemistry, vol. 275, No. 26, pp. 27823-27831 (2000).
Inohara, N. et al., “Genes with homology to DFF/CIDEs found inDrosophila melanogaster”, Cell Death and Differentiation, vol. 6, pp. 823-824 (1999).
Inohara, N. et al., “Genes with homology to mammalian apoptosis regulators identified in zebrafish”, Cell Death and Differentiation, vol. 7, pp. 509-510 (2000).
Iozzo, R.V., “Matrix Proteoglycans: From Molecular Design to Cellular Function”, Annu. Rev. Biochem., vol. 67, pp. 609-652 (1998).
Jacobs, J.R., “Perturbed Glial Scaffold Formation Precedes Axon Tract Malformation inDrosophilaMutants”, Journal of Neurobiology, vol. 24, No. 5, pp. 611-626 (1993).
Jacobs, J.R. et al., “Embryonic Development of Axon Pathways in theDrosophilaCNS. 1. A Glial Scafford Appears Before the First Growth Cones”, The Journal of Neuroscience, vol. 9, No. 7, pp. 2402-2411 (1989).
Jones, D.A. et al., “A Two-Step Adhesion Cascades for T Cell/Endothel
Bol David
Feder John N.
Mintier Gabriel A.
Ramanathan Chandra S.
Bristol--Myers Squibb Company
D'Amico Stephen C.
Hamud Fozia
O'Hara Eileen
LandOfFree
Human leucine-rich repeat containing protein expressed... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Human leucine-rich repeat containing protein expressed..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Human leucine-rich repeat containing protein expressed... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3851650